Cargando…

The evolution of phase I trials in cancer medicine: a critical review of the last decade

The advent of targeted therapies, combined with an unsustainable rate of failure in oncology drug development, has resulted in a number of new approaches to clinical trials. Early clinical trials are no exception, with efforts to improve the eventual success rate of late stage trials through evolvin...

Descripción completa

Detalles Bibliográficos
Autor principal: Tolcher, Anthony W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013329/
https://www.ncbi.nlm.nih.gov/pubmed/22059910
http://dx.doi.org/10.5732/cjc.011.10133